Lotus Bio Technology Development Stock Analysis
| LBTD Stock | USD 0.01 0.00 0.00% |
Lotus Bio-Technology's financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. Lotus Bio-Technology's financial risk is the risk to Lotus Bio-Technology stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that Lotus Bio-Technology's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Lotus Bio-Technology is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Lotus Bio-Technology to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Lotus Bio-Technology is said to be less leveraged. If creditors hold a majority of Lotus Bio-Technology's assets, the Company is said to be highly leveraged.
Lotus Bio Technology Development is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Lotus Bio-Technology pink sheet analysis is to determine its intrinsic value, which is an estimate of what Lotus Bio Technology Development is worth, separate from its market price. There are two main types of Lotus Bio-Technology's stock analysis: fundamental analysis and technical analysis.
The Lotus Bio-Technology pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Lotus Bio-Technology's ongoing operational relationships across important fundamental and technical indicators.
Lotus |
Lotus Pink Sheet Analysis Notes
About 60.0% of the company outstanding shares are owned by corporate insiders. The company had not issued any dividends in recent years. Lotus Bio Technology had 30:1 split on the 26th of June 2014. Lotus Bio-Technology Development Corp., a bio-technology development company, focuses on refining organic materials, and production of natural consumer related products in China. Lotus Bio-Technology Development Corp. was founded in 2011 and is based in Cave Creek, Arizona. Lotus Bio-Technology is traded on OTC Exchange in the United States.The quote for Lotus Bio Technology Development is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Lotus Bio Technology Development contact Zoltan Nagy at 480-275-2294 or learn more at www.lotusbiotechnologies.com.Lotus Bio Technology Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more pink sheets at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Lotus Bio-Technology's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Lotus Bio Technology Development or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Lotus Bio Technology generated a negative expected return over the last 90 days | |
| Lotus Bio Technology has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (19.55 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Lotus Bio Technology Development currently holds about 1 in cash with (17.75 K) of positive cash flow from operations. | |
| Roughly 60.0% of the company outstanding shares are owned by corporate insiders |
Lotus Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 13.78 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Lotus Bio-Technology's market, we take the total number of its shares issued and multiply it by Lotus Bio-Technology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Lotus Bio Technology, as well as the relationship between them.Lotus Bio Technology Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Lotus Bio-Technology middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Lotus Bio Technology. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Lotus Bio-Technology Outstanding Bonds
Lotus Bio-Technology issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Lotus Bio Technology uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Lotus bonds can be classified according to their maturity, which is the date when Lotus Bio Technology Development has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Lotus Bio Technology Debt to Cash Allocation
Many companies such as Lotus Bio-Technology, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Lotus Bio Technology Development currently holds 16.68 K in liabilities. Debt can assist Lotus Bio-Technology until it has trouble settling it off, either with new capital or with free cash flow. So, Lotus Bio-Technology's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Lotus Bio Technology sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Lotus to invest in growth at high rates of return. When we think about Lotus Bio-Technology's use of debt, we should always consider it together with cash and equity.Lotus Bio-Technology Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Lotus Bio-Technology's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Lotus Bio-Technology, which in turn will lower the firm's financial flexibility.Lotus Bio-Technology Corporate Bonds Issued
Most Lotus bonds can be classified according to their maturity, which is the date when Lotus Bio Technology Development has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
About Lotus Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Lotus Bio-Technology prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Lotus shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Lotus Bio-Technology. By using and applying Lotus Pink Sheet analysis, traders can create a robust methodology for identifying Lotus entry and exit points for their positions.
Lotus Bio-Technology Development Corp., a bio-technology development company, focuses on refining organic materials, and production of natural consumer related products in China. Lotus Bio-Technology Development Corp. was founded in 2011 and is based in Cave Creek, Arizona. Lotus Bio-Technology is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Lotus Bio-Technology to your portfolios without increasing risk or reducing expected return.Did you try this?
Run CEOs Directory Now
CEOs DirectoryScreen CEOs from public companies around the world |
| All Next | Launch Module |
Complementary Tools for Lotus Pink Sheet analysis
When running Lotus Bio-Technology's price analysis, check to measure Lotus Bio-Technology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Bio-Technology is operating at the current time. Most of Lotus Bio-Technology's value examination focuses on studying past and present price action to predict the probability of Lotus Bio-Technology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Bio-Technology's price. Additionally, you may evaluate how the addition of Lotus Bio-Technology to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |